[
    [
        {
            "time": "",
            "original_text": "CDE前首席科学家、恒瑞、AZ、上药、微芯思辨研发内涵！中国医药创新到底是研大还是发大？如何平衡？谁将有潜力成为万亿市值药企？",
            "features": {
                "keywords": [
                    "CDE",
                    "首席科学家",
                    "恒瑞",
                    "AZ",
                    "上药",
                    "微芯",
                    "医药创新",
                    "万亿市值"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "CDE前首席科学家、恒瑞、AZ、上药、微芯思辨研发内涵！中国医药创新到底是研大还是发大？如何平衡？谁将有潜力成为万亿市值药企？",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "未来十年，医药行业投资机会在这！",
            "features": {
                "keywords": [
                    "未来十年",
                    "医药行业",
                    "投资机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "未来十年，医药行业投资机会在这！",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "复星医药联席总裁陈玉卿：四个维度提升竞争力应对疫情挑战",
            "features": {
                "keywords": [
                    "复星医药",
                    "陈玉卿",
                    "竞争力",
                    "疫情挑战"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药联席总裁陈玉卿：四个维度提升竞争力应对疫情挑战",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]